1 Study Coverage 1.1 Insulin Glargine and Lispro Product Introduction 1.2 Market by Type 1.2.1 Global Insulin Glargine and Lispro Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Branded Drug 1.2.3 Biosimilar Drug 1.3 Market by Application 1.3.1 Global Insulin Glargine and Lispro Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Type I Dibetes 1.3.3 Type II Dibetes 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Insulin Glargine and Lispro Sales Estimates and Forecasts 2017-2028 2.2 Global Insulin Glargine and Lispro Revenue Estimates and Forecasts 2017-2028 2.3 Global Insulin Glargine and Lispro Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Insulin Glargine and Lispro Sales by Region 2.4.1 Global Insulin Glargine and Lispro Sales by Region (2017-2022) 2.4.2 Global Sales Insulin Glargine and Lispro by Region (2023-2028) 2.5 Global Insulin Glargine and Lispro Revenue by Region 2.5.1 Global Insulin Glargine and Lispro Revenue by Region (2017-2022) 2.5.2 Global Insulin Glargine and Lispro Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Insulin Glargine and Lispro Sales by Manufacturers 3.1.1 Global Top Insulin Glargine and Lispro Manufacturers by Sales (2017-2022) 3.1.2 Global Insulin Glargine and Lispro Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Glargine and Lispro in 2021 3.2 Global Insulin Glargine and Lispro Revenue by Manufacturers 3.2.1 Global Insulin Glargine and Lispro Revenue by Manufacturers (2017-2022) 3.2.2 Global Insulin Glargine and Lispro Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Insulin Glargine and Lispro Revenue in 2021 3.3 Global Insulin Glargine and Lispro Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Insulin Glargine and Lispro Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Insulin Glargine and Lispro Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Insulin Glargine and Lispro Sales by Type 4.1.1 Global Insulin Glargine and Lispro Historical Sales by Type (2017-2022) 4.1.2 Global Insulin Glargine and Lispro Forecasted Sales by Type (2023-2028) 4.1.3 Global Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) 4.2 Global Insulin Glargine and Lispro Revenue by Type 4.2.1 Global Insulin Glargine and Lispro Historical Revenue by Type (2017-2022) 4.2.2 Global Insulin Glargine and Lispro Forecasted Revenue by Type (2023-2028) 4.2.3 Global Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) 4.3 Global Insulin Glargine and Lispro Price by Type 4.3.1 Global Insulin Glargine and Lispro Price by Type (2017-2022) 4.3.2 Global Insulin Glargine and Lispro Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Insulin Glargine and Lispro Sales by Application 5.1.1 Global Insulin Glargine and Lispro Historical Sales by Application (2017-2022) 5.1.2 Global Insulin Glargine and Lispro Forecasted Sales by Application (2023-2028) 5.1.3 Global Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) 5.2 Global Insulin Glargine and Lispro Revenue by Application 5.2.1 Global Insulin Glargine and Lispro Historical Revenue by Application (2017-2022) 5.2.2 Global Insulin Glargine and Lispro Forecasted Revenue by Application (2023-2028) 5.2.3 Global Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) 5.3 Global Insulin Glargine and Lispro Price by Application 5.3.1 Global Insulin Glargine and Lispro Price by Application (2017-2022) 5.3.2 Global Insulin Glargine and Lispro Price Forecast by Application (2023-2028) 6 North America 6.1 North America Insulin Glargine and Lispro Market Size by Type 6.1.1 North America Insulin Glargine and Lispro Sales by Type (2017-2028) 6.1.2 North America Insulin Glargine and Lispro Revenue by Type (2017-2028) 6.2 North America Insulin Glargine and Lispro Market Size by Application 6.2.1 North America Insulin Glargine and Lispro Sales by Application (2017-2028) 6.2.2 North America Insulin Glargine and Lispro Revenue by Application (2017-2028) 6.3 North America Insulin Glargine and Lispro Market Size by Country 6.3.1 North America Insulin Glargine and Lispro Sales by Country (2017-2028) 6.3.2 North America Insulin Glargine and Lispro Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Insulin Glargine and Lispro Market Size by Type 7.1.1 Europe Insulin Glargine and Lispro Sales by Type (2017-2028) 7.1.2 Europe Insulin Glargine and Lispro Revenue by Type (2017-2028) 7.2 Europe Insulin Glargine and Lispro Market Size by Application 7.2.1 Europe Insulin Glargine and Lispro Sales by Application (2017-2028) 7.2.2 Europe Insulin Glargine and Lispro Revenue by Application (2017-2028) 7.3 Europe Insulin Glargine and Lispro Market Size by Country 7.3.1 Europe Insulin Glargine and Lispro Sales by Country (2017-2028) 7.3.2 Europe Insulin Glargine and Lispro Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Insulin Glargine and Lispro Market Size by Type 8.1.1 Asia Pacific Insulin Glargine and Lispro Sales by Type (2017-2028) 8.1.2 Asia Pacific Insulin Glargine and Lispro Revenue by Type (2017-2028) 8.2 Asia Pacific Insulin Glargine and Lispro Market Size by Application 8.2.1 Asia Pacific Insulin Glargine and Lispro Sales by Application (2017-2028) 8.2.2 Asia Pacific Insulin Glargine and Lispro Revenue by Application (2017-2028) 8.3 Asia Pacific Insulin Glargine and Lispro Market Size by Region 8.3.1 Asia Pacific Insulin Glargine and Lispro Sales by Region (2017-2028) 8.3.2 Asia Pacific Insulin Glargine and Lispro Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Insulin Glargine and Lispro Market Size by Type 9.1.1 Latin America Insulin Glargine and Lispro Sales by Type (2017-2028) 9.1.2 Latin America Insulin Glargine and Lispro Revenue by Type (2017-2028) 9.2 Latin America Insulin Glargine and Lispro Market Size by Application 9.2.1 Latin America Insulin Glargine and Lispro Sales by Application (2017-2028) 9.2.2 Latin America Insulin Glargine and Lispro Revenue by Application (2017-2028) 9.3 Latin America Insulin Glargine and Lispro Market Size by Country 9.3.1 Latin America Insulin Glargine and Lispro Sales by Country (2017-2028) 9.3.2 Latin America Insulin Glargine and Lispro Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Insulin Glargine and Lispro Market Size by Type 10.1.1 Middle East and Africa Insulin Glargine and Lispro Sales by Type (2017-2028) 10.1.2 Middle East and Africa Insulin Glargine and Lispro Revenue by Type (2017-2028) 10.2 Middle East and Africa Insulin Glargine and Lispro Market Size by Application 10.2.1 Middle East and Africa Insulin Glargine and Lispro Sales by Application (2017-2028) 10.2.2 Middle East and Africa Insulin Glargine and Lispro Revenue by Application (2017-2028) 10.3 Middle East and Africa Insulin Glargine and Lispro Market Size by Country 10.3.1 Middle East and Africa Insulin Glargine and Lispro Sales by Country (2017-2028) 10.3.2 Middle East and Africa Insulin Glargine and Lispro Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Sanofi S.A 11.1.1 Sanofi S.A Corporation Information 11.1.2 Sanofi S.A Overview 11.1.3 Sanofi S.A Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Sanofi S.A Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi S.A Recent Developments 11.2 Eli Lilly and Company 11.2.1 Eli Lilly and Company Corporation Information 11.2.2 Eli Lilly and Company Overview 11.2.3 Eli Lilly and Company Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly and Company Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly and Company Recent Developments 11.3 Biocon Limited 11.3.1 Biocon Limited Corporation Information 11.3.2 Biocon Limited Overview 11.3.3 Biocon Limited Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Biocon Limited Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Biocon Limited Recent Developments 11.4 Cipla Limited 11.4.1 Cipla Limited Corporation Information 11.4.2 Cipla Limited Overview 11.4.3 Cipla Limited Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Cipla Limited Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Cipla Limited Recent Developments 11.5 Gan & Lee Pharmaceutical Ltd. 11.5.1 Gan & Lee Pharmaceutical Ltd. Corporation Information 11.5.2 Gan & Lee Pharmaceutical Ltd. Overview 11.5.3 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Gan & Lee Pharmaceutical Ltd. Recent Developments 11.6 Julphar Diabetes LLC 11.6.1 Julphar Diabetes LLC Corporation Information 11.6.2 Julphar Diabetes LLC Overview 11.6.3 Julphar Diabetes LLC Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Julphar Diabetes LLC Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Julphar Diabetes LLC Recent Developments 11.7 Merck & Co. 11.7.1 Merck & Co. Corporation Information 11.7.2 Merck & Co. Overview 11.7.3 Merck & Co. Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Merck & Co. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Merck & Co. Recent Developments 11.8 Novo Nordisk A/S 11.8.1 Novo Nordisk A/S Corporation Information 11.8.2 Novo Nordisk A/S Overview 11.8.3 Novo Nordisk A/S Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Novo Nordisk A/S Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Novo Nordisk A/S Recent Developments 11.9 SAJA Pharmaceuticals 11.9.1 SAJA Pharmaceuticals Corporation Information 11.9.2 SAJA Pharmaceuticals Overview 11.9.3 SAJA Pharmaceuticals Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 SAJA Pharmaceuticals Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 SAJA Pharmaceuticals Recent Developments 11.10 Wockhardt Ltd. 11.10.1 Wockhardt Ltd. Corporation Information 11.10.2 Wockhardt Ltd. Overview 11.10.3 Wockhardt Ltd. Insulin Glargine and Lispro Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Wockhardt Ltd. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Wockhardt Ltd. Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Insulin Glargine and Lispro Industry Chain Analysis 12.2 Insulin Glargine and Lispro Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Insulin Glargine and Lispro Production Mode & Process 12.4 Insulin Glargine and Lispro Sales and Marketing 12.4.1 Insulin Glargine and Lispro Sales Channels 12.4.2 Insulin Glargine and Lispro Distributors 12.5 Insulin Glargine and Lispro Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Insulin Glargine and Lispro Industry Trends 13.2 Insulin Glargine and Lispro Market Drivers 13.3 Insulin Glargine and Lispro Market Challenges 13.4 Insulin Glargine and Lispro Market Restraints 14 Key Findings in The Global Insulin Glargine and Lispro Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Insulin Glargine and Lispro Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Branded Drug Table 3. Major Manufacturers of Biosimilar Drug Table 4. Global Insulin Glargine and Lispro Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Insulin Glargine and Lispro Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Insulin Glargine and Lispro Sales by Region (2017-2022) & (Liter) Table 7. Global Insulin Glargine and Lispro Sales Market Share by Region (2017-2022) Table 8. Global Insulin Glargine and Lispro Sales by Region (2023-2028) & (Liter) Table 9. Global Insulin Glargine and Lispro Sales Market Share by Region (2023-2028) Table 10. Global Insulin Glargine and Lispro Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Insulin Glargine and Lispro Revenue Market Share by Region (2017-2022) Table 12. Global Insulin Glargine and Lispro Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Insulin Glargine and Lispro Revenue Market Share by Region (2023-2028) Table 14. Global Insulin Glargine and Lispro Sales by Manufacturers (2017-2022) & (Liter) Table 15. Global Insulin Glargine and Lispro Sales Share by Manufacturers (2017-2022) Table 16. Global Insulin Glargine and Lispro Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Insulin Glargine and Lispro Revenue Share by Manufacturers (2017-2022) Table 18. Insulin Glargine and Lispro Price by Manufacturers (2017-2022) &(USD/mL) Table 19. Global Insulin Glargine and Lispro Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Insulin Glargine and Lispro by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Glargine and Lispro as of 2021) Table 21. Insulin Glargine and Lispro Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Insulin Glargine and Lispro Product Offered Table 23. Date of Manufacturers Enter into Insulin Glargine and Lispro Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 26. Global Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 27. Global Insulin Glargine and Lispro Sales Share by Type (2017-2022) Table 28. Global Insulin Glargine and Lispro Sales Share by Type (2023-2028) Table 29. Global Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Insulin Glargine and Lispro Revenue Share by Type (2017-2022) Table 32. Global Insulin Glargine and Lispro Revenue Share by Type (2023-2028) Table 33. Insulin Glargine and Lispro Price by Type (2017-2022) & (USD/mL) Table 34. Global Insulin Glargine and Lispro Price Forecast by Type (2023-2028) & (USD/mL) Table 35. Global Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 36. Global Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 37. Global Insulin Glargine and Lispro Sales Share by Application (2017-2022) Table 38. Global Insulin Glargine and Lispro Sales Share by Application (2023-2028) Table 39. Global Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Insulin Glargine and Lispro Revenue Share by Application (2017-2022) Table 42. Global Insulin Glargine and Lispro Revenue Share by Application (2023-2028) Table 43. Insulin Glargine and Lispro Price by Application (2017-2022) & (USD/mL) Table 44. Global Insulin Glargine and Lispro Price Forecast by Application (2023-2028) & (USD/mL) Table 45. North America Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 46. North America Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 47. North America Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 50. North America Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 51. North America Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Insulin Glargine and Lispro Sales by Country (2017-2022) & (Liter) Table 54. North America Insulin Glargine and Lispro Sales by Country (2023-2028) & (Liter) Table 55. North America Insulin Glargine and Lispro Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Insulin Glargine and Lispro Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 58. Europe Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 59. Europe Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 62. Europe Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 63. Europe Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Insulin Glargine and Lispro Sales by Country (2017-2022) & (Liter) Table 66. Europe Insulin Glargine and Lispro Sales by Country (2023-2028) & (Liter) Table 67. Europe Insulin Glargine and Lispro Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Insulin Glargine and Lispro Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 70. Asia Pacific Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 71. Asia Pacific Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 74. Asia Pacific Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 75. Asia Pacific Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Insulin Glargine and Lispro Sales by Region (2017-2022) & (Liter) Table 78. Asia Pacific Insulin Glargine and Lispro Sales by Region (2023-2028) & (Liter) Table 79. Asia Pacific Insulin Glargine and Lispro Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Insulin Glargine and Lispro Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 82. Latin America Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 83. Latin America Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 86. Latin America Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 87. Latin America Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Insulin Glargine and Lispro Sales by Country (2017-2022) & (Liter) Table 90. Latin America Insulin Glargine and Lispro Sales by Country (2023-2028) & (Liter) Table 91. Latin America Insulin Glargine and Lispro Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Insulin Glargine and Lispro Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Insulin Glargine and Lispro Sales by Type (2017-2022) & (Liter) Table 94. Middle East and Africa Insulin Glargine and Lispro Sales by Type (2023-2028) & (Liter) Table 95. Middle East and Africa Insulin Glargine and Lispro Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Insulin Glargine and Lispro Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Insulin Glargine and Lispro Sales by Application (2017-2022) & (Liter) Table 98. Middle East and Africa Insulin Glargine and Lispro Sales by Application (2023-2028) & (Liter) Table 99. Middle East and Africa Insulin Glargine and Lispro Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Insulin Glargine and Lispro Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2017-2022) & (Liter) Table 102. Middle East and Africa Insulin Glargine and Lispro Sales by Country (2023-2028) & (Liter) Table 103. Middle East and Africa Insulin Glargine and Lispro Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Insulin Glargine and Lispro Revenue by Country (2023-2028) & (US$ Million) Table 105. Sanofi S.A Corporation Information Table 106. Sanofi S.A Description and Major Businesses Table 107. Sanofi S.A Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 108. Sanofi S.A Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 109. Sanofi S.A Recent Developments Table 110. Eli Lilly and Company Corporation Information Table 111. Eli Lilly and Company Description and Major Businesses Table 112. Eli Lilly and Company Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 113. Eli Lilly and Company Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Eli Lilly and Company Recent Developments Table 115. Biocon Limited Corporation Information Table 116. Biocon Limited Description and Major Businesses Table 117. Biocon Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 118. Biocon Limited Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 119. Biocon Limited Recent Developments Table 120. Cipla Limited Corporation Information Table 121. Cipla Limited Description and Major Businesses Table 122. Cipla Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 123. Cipla Limited Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Cipla Limited Recent Developments Table 125. Gan & Lee Pharmaceutical Ltd. Corporation Information Table 126. Gan & Lee Pharmaceutical Ltd. Description and Major Businesses Table 127. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 128. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 129. Gan & Lee Pharmaceutical Ltd. Recent Developments Table 130. Julphar Diabetes LLC Corporation Information Table 131. Julphar Diabetes LLC Description and Major Businesses Table 132. Julphar Diabetes LLC Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 133. Julphar Diabetes LLC Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Julphar Diabetes LLC Recent Developments Table 135. Merck & Co. Corporation Information Table 136. Merck & Co. Description and Major Businesses Table 137. Merck & Co. Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 138. Merck & Co. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 139. Merck & Co. Recent Developments Table 140. Novo Nordisk A/S Corporation Information Table 141. Novo Nordisk A/S Description and Major Businesses Table 142. Novo Nordisk A/S Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 143. Novo Nordisk A/S Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Novo Nordisk A/S Recent Developments Table 145. SAJA Pharmaceuticals Corporation Information Table 146. SAJA Pharmaceuticals Description and Major Businesses Table 147. SAJA Pharmaceuticals Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 148. SAJA Pharmaceuticals Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 149. SAJA Pharmaceuticals Recent Developments Table 150. Wockhardt Ltd. Corporation Information Table 151. Wockhardt Ltd. Description and Major Businesses Table 152. Wockhardt Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022) Table 153. Wockhardt Ltd. Insulin Glargine and Lispro Product Model Numbers, Pictures, Descriptions and Specifications Table 154. Wockhardt Ltd. Recent Developments Table 155. Key Raw Materials Lists Table 156. Raw Materials Key Suppliers Lists Table 157. Insulin Glargine and Lispro Distributors List Table 158. Insulin Glargine and Lispro Customers List Table 159. Insulin Glargine and Lispro Market Trends Table 160. Insulin Glargine and Lispro Market Drivers Table 161. Insulin Glargine and Lispro Market Challenges Table 162. Insulin Glargine and Lispro Market Restraints Table 163. Research Programs/Design for This Report Table 164. Key Data Information from Secondary Sources Table 165. Key Data Information from Primary Sources List of Figures Figure 1. Insulin Glargine and Lispro Product Picture Figure 3. Global Insulin Glargine and Lispro Market Share by Type in 2021 & 2028 Figure 3. Branded Drug Product Picture Figure 4. Biosimilar Drug Product Picture Figure 5. Global Insulin Glargine and Lispro Market Share by Application in 2021 & 2028 Figure 6. Type I Dibetes Figure 7. Type II Dibetes Figure 8. Insulin Glargine and Lispro Report Years Considered Figure 9. Global Insulin Glargine and Lispro Sales 2017-2028 (Liter) Figure 10. Global Insulin Glargine and Lispro Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Insulin Glargine and Lispro Revenue 2017-2028 (US$ Million) Figure 12. Global Insulin Glargine and Lispro Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 13. Global Insulin Glargine and Lispro Sales Market Share by Region (2017-2022) Figure 14. Global Insulin Glargine and Lispro Sales Market Share by Region (2023-2028) Figure 15. North America Insulin Glargine and Lispro Sales YoY (2017-2028) & (Liter) Figure 16. North America Insulin Glargine and Lispro Revenue YoY (2017-2028) & (US$ Million) Figure 17. Europe Insulin Glargine and Lispro Sales YoY (2017-2028) & (Liter) Figure 18. Europe Insulin Glargine and Lispro Revenue YoY (2017-2028) & (US$ Million) Figure 19. Asia-Pacific Insulin Glargine and Lispro Sales YoY (2017-2028) & (Liter) Figure 20. Asia-Pacific Insulin Glargine and Lispro Revenue YoY (2017-2028) & (US$ Million) Figure 21. Latin America Insulin Glargine and Lispro Sales YoY (2017-2028) & (Liter) Figure 22. Latin America Insulin Glargine and Lispro Revenue YoY (2017-2028) & (US$ Million) Figure 23. Middle East & Africa Insulin Glargine and Lispro Sales YoY (2017-2028) & (Liter) Figure 24. Middle East & Africa Insulin Glargine and Lispro Revenue YoY (2017-2028) & (US$ Million) Figure 25. The Insulin Glargine and Lispro Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 26. The Top 5 and 10 Largest Manufacturers of Insulin Glargine and Lispro in the World: Market Share by Insulin Glargine and Lispro Revenue in 2021 Figure 27. Global Insulin Glargine and Lispro Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 28. Global Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 29. Global Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 30. Global Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 31. Global Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 32. North America Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 33. North America Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 34. North America Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 35. North America Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 36. North America Insulin Glargine and Lispro Sales Share by Country (2017-2028) Figure 37. North America Insulin Glargine and Lispro Revenue Share by Country (2017-2028) Figure 38. U.S. Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 39. Canada Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 40. Europe Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 41. Europe Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 42. Europe Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 43. Europe Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 44. Europe Insulin Glargine and Lispro Sales Share by Country (2017-2028) Figure 45. Europe Insulin Glargine and Lispro Revenue Share by Country (2017-2028) Figure 46. Germany Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 47. France Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 48. U.K. Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 49. Italy Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 50. Russia Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 51. Asia Pacific Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 52. Asia Pacific Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 53. Asia Pacific Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 54. Asia Pacific Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 55. Asia Pacific Insulin Glargine and Lispro Sales Share by Region (2017-2028) Figure 56. Asia Pacific Insulin Glargine and Lispro Revenue Share by Region (2017-2028) Figure 57. China Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 58. Japan Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 59. South Korea Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 60. India Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 61. Australia Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 62. Taiwan Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 63. Indonesia Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 64. Thailand Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 65. Malaysia Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 66. Philippines Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 67. Latin America Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 68. Latin America Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 69. Latin America Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 70. Latin America Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 71. Latin America Insulin Glargine and Lispro Sales Share by Country (2017-2028) Figure 72. Latin America Insulin Glargine and Lispro Revenue Share by Country (2017-2028) Figure 73. Mexico Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 74. Brazil Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 75. Argentina Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 76. Middle East and Africa Insulin Glargine and Lispro Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Insulin Glargine and Lispro Revenue Market Share by Type (2017-2028) Figure 78. Middle East and Africa Insulin Glargine and Lispro Sales Market Share by Application (2017-2028) Figure 79. Middle East and Africa Insulin Glargine and Lispro Revenue Market Share by Application (2017-2028) Figure 80. Middle East and Africa Insulin Glargine and Lispro Sales Share by Country (2017-2028) Figure 81. Middle East and Africa Insulin Glargine and Lispro Revenue Share by Country (2017-2028) Figure 82. Turkey Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 83. Saudi Arabia Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 84. UAE Insulin Glargine and Lispro Revenue (2017-2028) & (US$ Million) Figure 85. Insulin Glargine and Lispro Value Chain Figure 86. Insulin Glargine and Lispro Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Sanofi S.A Eli Lilly and Company Biocon Limited Cipla Limited Gan & Lee Pharmaceutical Ltd. Julphar Diabetes LLC Merck & Co. Novo Nordisk A/S SAJA Pharmaceuticals Wockhardt Ltd.